Bariatric Times

Insights into Patient Pop with Obesity 2016

A peer-reviewed, evidence-based journal that promotes clinical development and metabolic insights in total bariatric patient care for the healthcare professional

Issue link:

Contents of this Issue


Page 24 of 26

Bariatric Times • December 2016 • Supplement C C25 reFereNCeS 1. Jensen M, Ryan D, Donato K. Guidelines (2013) for managing overweight and obesity in adults. Obesity. 2014;22(S@):S1–S410. 2. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS g uideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S139-S140. 3. Apovian C, Aronne L, Bessesen D, et al. Pharmacological management of obesity: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(2):342–362. 4. Garvey W, Garber A, Mechanick J, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease. Endocr Pract. 2014;20(9):977–989. 5. Garvey W, Mechanick J, Brett E, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guideliens for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3):1–203. 6. Seger J, Horn D, Westman E, et al. Obesity Algorithm 2015. ty-algorithm/. Accessed November 15, 2016. 7. The National Academics of Sciences Engineering Medicine. Standards for Developing Trustworthy Clinical Practice Guidelines. Health and Medicine 2011; http://www.nationalacademies.or g/hmd/Reports/2011/Clinical- Practice-Guidelines-We-Can-Trust /Standards.aspx. Accessed November 15, 2016. 8. Carrero J, Avesani C. Pros and cons of body mass index as a nutritional and risk assessment tool in dialysis patients. Semin Dial. 2015;28(1):48–58. 9. van de Laar A. Bariatric Outcomes Longitudinal Database (BOLD) suggests excess weight loss and excess BMI loss to be inappropriate outcome measures, demonstrating better alternatives. O bes Surg. 2012;22(12):1843–1847. 10. Martin L, Seton G, Aldred B, et al. When body mass index fails to measure up: perinephric and periumbilical fat as predictors of operative risk. Am J Surg. 2016;S0002-9610(16):30545. 11. What is healthy weight loss? Losing Weight 2015; ght/losing_weight/. Accessed November 15, 2016. 12. Wing R, Lang W, Wadden T, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481-1486. 13. Franz M, Boucher J, Rutten-Ramos S, VanWormer J. Lifestyle weight- loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic reivew and meta-analysis of randomized clinical trials. J Acad Nutr Diet. 2015;115(9):1447–1463. 14. Magkos F, Fraterrigo G, Yoshino J. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23:591–601. 15. Kuk J, Ardern C, Church T, et al. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011;36(4):570–576. 16. Zhang S, Manne S, Lin J, Yang J. Characteristics of patients potentially eligible for pharmacotherapy for weight loss in primary care practice in the United States. Obes Sci Pract. 2016;2(2):104–114. 17. Kahan S. Overweight and obesity management strategies. Am J Manag Care. 2016;22(7 Suppl):186–196. 18. Horn D, Ryan DS. Answers to clinical questions in the primary care management of people with obesity: principles of patient management. J Fam Pract. 2016;65(7 Suppl):S9–S13. 19. Skolnik N, Horn D. Answers to clinical questions in primary care management of people with o besity: lifestyle management. J Fam Pract. 2016;65(7 Suppl):S13–S16. 20. Nobles J, Radley D, Dimitri P, Sharman K. Psychosocial interventions in the treatment of severe adolescent obesity: the SHINE program. J Adolesc Health. 2016;59(5):523–529. 21. Grandner M, Seixas A, Shetty S, Shenoy S. Sleep duration and diabetes risk: population trends and potential mechanisms. Curr Diab Rep. 2016;16(11):106. 22. Rebello C, O'Neil P, Horn D, Greenway F. Timing the discussion of antiobesity medications during obesity treatment. Obesity. 2016;24(10):2027–2028. 23. Camilleri M, Acosta A. Gastrointestinal traits: individualizing therapy for obesity with drugs and devices. Gastrointest Endosc. 2016;83(1):48–56. 24. Chiang A, Ryou M. Endoscopic treatment of obesity. Curr Opin Gastroenterol. 2016;32(6):487–491. 25. Goyal D, Watson R. Endoscopic Bariatric Therapies. Curr Gastroenterol Rep. 2016;18(6):26. 26. Cripps C, Roslin M. Endoluminal treatments for obesity and related hypertension: updates, review, and clinical perspective. Curr Hypertens Rep. 2016;18(11):79. 27. Zhang Y, Du SQ, Fang LC, Yao S, Chen S. Retrograde gastic electrical stimulation suppresses calorie intake in obese subjects. Obesity (Silver Spring). 2014;22(6):1447–1451. 28. Neylan C, Kannan U, Dempsey D, Williams N, Dumon K. The surgical management of obesity. Gastroenterol Clin North Am. 2016;45(4):689–703. 29. Min JK, Chiu D, Wang Y. Variation in the heritability of body mass index based on diverse twin studies: a systematic review. Obes Insights into the Patient Population with Obesity: Assessment and Treatment

Articles in this issue

Links on this page

Archives of this issue

view archives of Bariatric Times - Insights into Patient Pop with Obesity 2016